Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by imatryinon Sep 26, 2017 10:08am
197 Views
Post# 26741858

RE:RE:RE:Refractory Septic Shock vs. Retweets

RE:RE:RE:Refractory Septic Shock vs. Retweets I'd really like to understand why they do this.  If there was no substance here and they knew they wouldn't get approval, they would be pumping out fake news to drive up their value so they could unload as much as possible at elevated prices.  That isn't the case.  They are for the most part radio silent, with 0 marketing.  They are clearly intending to keep the SP artificially low.  The question is why!  They are a public company so they have to divulge materially-impacting agreements and activities.  I dunno.  Anyone?

mercedesman wrote:
Biotech675 wrote: Using old data to stimulate new investment, what a good idea... if only spectral did the same. Chan is good at spinning things in a way that make them seem new and exciting but in reality those results were already published early 2016



its as if WE are generating the new & hard scientific findings ( e.g. Positive effects of endotoxin removal) and they release the " news" in the US and spin it around a few times in the process. How fun for their shareholders! ( e.g. They are up today we are down). They generate shareholder value for their shareholders using OPM ( other people's money)  - namely hard earned money accepted from Spectral shareholders.  They don't even have to run any costly Trials.  It's a good gig....for them!

PS didn't Apple ( a US Company) steal a good idea from RIM ( a Canadian company) and out market them ?



Bullboard Posts